How should we measure nutrition-induced improvements in memory?

European Journal of Nutrition

Volumn 44, Issue 8, 2005, Pages 485-498

  Benton, David ^a   Kallus, K Wolfgang ^b   Schmitt, Jeroen A J ^c  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF GRAZ   (Austria)

^c NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

Aging; Dementia; Memory; Phosphatidylserine; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; PHOSPHATIDYLSERINE;

AGING; ALZHEIMER DISEASE; ARTICLE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; DEMENTIA; DIET; DISEASE SEVERITY; HUMAN; MEMORY; NUTRITION; PERSONALITY TEST; POPULATION; RATING SCALE; VERBAL MEMORY;

AGED; AGING; COGNITION; COGNITION DISORDERS; DEMENTIA; HUMANS; MEMORY; MENTAL RECALL; NEUROPSYCHOLOGICAL TESTS; NUTRITION PHYSIOLOGY; PHOSPHATIDYLSERINES; VITAMIN E;

EID: 28644443676     PISSN: 14366207     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00394-005-0583-6     Document Type: Article

References (67)

1. Baddeley A (1992) Working memory. Science 255:556-559
2. Baddeley A (2000) The episodic buffer: a new component of working memory? Trends Cogn Sci 4:417-423
3. Shallice T, Fletcher P, Frityh CD, Grasby P, Frackowiak RSJ, Dolan RJ (1994) Brain regions associated with acquisition and retrieval of verbal episodic memory. Nature 368:633-635
4. Lee ACH, Robbins TW, Graham KS, Owen AM (2002) Pray or Prey? Dissociation of semantic memory retrieval from episodic memory processes using positron emission tomography and a novel homophone task. Neuroimage 16:724-735
5. Grady CL, Craik FIM (2000) Changes in memory processing with age. Curr Opin Neurobiol 10:224-231
6. Balota DA, Dolan PO, Duchek JM (2000) Memory changes in healthy older adults. In: Tulving E, Craik FIM (eds) The Oxford Handbook of Memory. Oxford University Press, Oxford, pp 395-409
7. Anderson ND, Craik FIM (2000) Memory in the aging brain. In: Tulving E, Craik FIM (eds) The Oxford Handbook of Memory. Oxford University Press, Oxford, pp 411-425
8. Burke DM, MacKay DG, Worthley JS, Wade E (1991) On the tip-of-the-tongue: What causes word finding failures in young and older adults? J Mem Lang 30:542-579
9. Collie A, Maruff P (2000) The neuropsychology of preclinical Alzheimer's disease and mild cognitive impairment. Neurosci Biobehav Rev 24:365-374
10. Nilsson LG (2003) Memory function in normal aging. Acta Neurol Scand 179(Suppl):7-13
11. Park HL, O'Connell JE, Thomson RG (2003) A systematic review of cognitive decline in the general elderly population. Int J Ger Psychiatry 18:1121-1134
12. Brayne C, Huppert F, Paykel E, Gill C (1992) The Cambridge project for later life: design and preliminary results. Neuroepidemiol 11(Suppl 1):71-75
13. Lyketsos C, Chen L-S, Anthony J (1999) Cognitive decline in adulthood: an 11.5 year follow-up of the Baltimore epidemiology catchment area study. Am J Psychiat 156:58-65
14. Bischkopf J, Busse A, Angermeyer MC (2002) Mild cognitive impairment - a review of prevalence, incidence and outcome according to current approaches. Acta Psychiatr Scand 106:403-414
15. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: clinical characterisation and outcome. Arch Neurol 56:303-308
16. Newman SK, Warrington EK, Kennedy AM, Rossor M (1994) The earliest cognitive change in a person with familial Alzheimer's disease: presymptomatic neuropsychological features in a pedigree with familial Alzheimer's disease confirmed at autopsy. J Neurol Neurosurg Psychiatry 57:967-972
17. Hodges JR (2000) Memory in the dementias. In: Tulving E, Craik FIM (eds) The Oxford Handbook of Memory. Oxford University Press, Oxford, pp 441-459
18. Lorentz WJ, Scanlan JM, Borson S (2002) Brief screening tests for dementia. Can J Psychiatry 47:723-733
19. Brodaty H, Pond D, Kemp NM, Luscombe G, Harding L, Berman K, Huppert FA (2002) The GPCOG: a new screening test for dementia designed for general practice. J Am Geriatr Soc 50:530-534
20. Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198
21. Feher EP, Mahurin RK, Doody RS, Cooke N, Sims J, Pirozzolo FJ (1992) Establishing the limits of the Mini-Mental State: Examination of sub-tests. Arch Neurol 49:87-92
22. Wind AW, Schellevis FG, Van Staveren G, Scholten RP, Jonker C, Van Eijk JTM (1997) Limitations of the mini-mental state examination for diagnosing dementia in general practice. Int J Geriatr Psychiatry 12:101-108
23. Pfeiffer E (1975) A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Amer Geriatr Soc 23:433-441
24. Smith G, Della Sala S, Logie RH, Maylor EA (2000) Prospective and retrospective memory in normal ageing and dementia: a questionnaire study. Memory 8:311-321
25. Crawford JR, Smith G, Maylor EA, Della Sala S, Logie RH (2000) The prospective and retrospective memory questionnaire (PRMQ): normative data and later structure in a large non-clinical sample. Memory 11:261-275
26. rd UK Edition. Psychological Corporation, New York
27. Taylor EM (1959) The appraisal of children with cerebral deficits. Harvard University Press, Cambridge, MA
28. Buschke H, Fuld PA (1974) Evaluating storage, retention and retrieval in disordered memory and learning. Neurology 11:1019-1025
29. O'Connell ME, Tuokko H (2002) The 12-item Buschke memory test: appropriate for use across levels of impairment. Appl Neuropsychol 9:226-233
30. Wood FB, Ebert V, Kinsbourne M (1982) The episodic-semantic memory distinction in memory and amnesia: clinical and experimental observations. In: Cermak L (ed) Memory and amnesia. Lawrence Erlbaum Associates, Hillsdale, NJ, pp 167-194
31. Greene JD, Hodges JR (1996) Identification of famous faces and famous names in early Alzheimer's disease. Relationship to anterograde episodic and general semantic memory. Brain 119:111-128
32. Uttl B (2005) Measurement of Individual Differences. Psychol Sci 16:460-467
33. Uttl B (2005) Age-related changes in event-cued prospective memory proper. In: Ohta N, MacLeod CM (eds) Dynamic cognitive processes. Springer-Verlag, Tokyo, pp 273-303
34. Theisen ME, Rapport LJ, Axelrod BN, Brines DB (1998) Effects of practice in repeated administrations of the Wechsler Memory Scale Revised in normal adults. Assessment 5:85-92
35. Canizares S, Boget T, Salamero M, Rumia J, Elices E, Arroyo S (2000) Reliability and clinical usefulness of the short forms of the Wechsler memory scale (revised) in patients with epilepsy. Epilepsy Res 41:97-106
36. Delaney RC, Prevey ML, Cramer J, Mattson RH (1992) Test-retest comparability and control subject data for the Rey-Auditory Verbal Learning Test and Rey-Osterrieth/Taylor Complex Figures. Arch Clin Neuropsychol 7:523-528
37. La Rue A, Koehler KM, Wayne SJ, Chiulli SJ, Haaland KY, Garry PJ (1997) Nutritional status and cognitive functioning in a normally aging sample: a 6-y reassessment. Am J Clin Nutr 65:20-29
38. Rey A (1964) L'examen clinique en psychologie. Presses Universitaires de France
39. Mitrushina M, Boone KB, Razani LJ, D'Elia LF (2005) Handbook of Normative Data for Neuropsychological Assessment. Oxford University Press, Oxford
40. Pepeu G, Pepeu IM, Amaducci L (1996) A review of phosphatidylserine pharmacological and clinical effects. Is phosphatidylserine a drug for the ageing brain? Pharmacol Res 33:73-80
41. Nunzi MG, Milan F, Guidolin D, Toffano G (1987) Dendritic spine loss in hippocampus of aged rats. Effect of brain phosphatidylserine administration. Neurobiol Aging 8:501-510
42. Klinkhammer P, Szelies B, Heiss W (1990) Effect of phosphatidylserine on cerebral glucose metabolism in Alzheimer's Disease. Dementia 1:197-201
43. Delwaide PJ, Gyselynck-Mambourg AM, Hurlet A, Ylieff MPJ (1986) Double-blind randomized controlled study of phosphatidylserine in demented subjects. Acta Neurol Scand 73:136-140
44. Palmieri G, Palmieri R, Inzoli MR, Agrati AM, Vargiu A (1987) Double-blind controlled trial of phosphatidylserine in subjects with senile mental deterioration. Clin Trials J 24:73-83
45. Villardita JC, Griolis S, Salmeri G, Nicoletti F, Pennisi G (1987) Multicentre clinical trial of brain phosphatidylserine in elderly subjects with mental deterioration. Clin Trials J 24:84-93
46. Engel RR, Satzger W, Gunther W, Kathmann N, Bove D, Gerke S, Munch U, Hippius H (1992) Double-blind cross-over study of phosphatidylserine vs. placebo in subjects with early cognitive deterioration of the Alzheimer type. Eur Neuropsychopharmacol 2:149-155
47. Crook T, Petrie W, Wells C, Massari DC (1992) Effects of phosphatidylserine in Alzheimer's disease. Psychopharmacol Bull 28:61-66
48. Cenacchi T, Bertoldin T, Farina C, Fiori MG, Crepaldi G (1993) Cognitive decline in the elderly: A double blind, placebo-controlled multicenter study on efficacy of phosphatidylserine administration. Aging Clin Exp Res 5:123-133
49. Heiss WD, Kessler J, Mielke R, Szelies B, Herholz K (1994) Long-term effects of phosphatidylserine, pyritinol, and cognitive training in Alzheimer's disease. A neuropsychological, EEG, and PET investigation. Dementia 5:88-98
50. Maggioni M, Picotti GB, Bondiolotti GP, Panerai A, Cenacchi T, Nobile P, Brambilla F (1990) Effects of phosphatidylserine therapy in geriatric patients with depressive disorders. Acta Psychiatr Scand 81:265-270
51. Crook TH, Tinklenberg J, Yesavage J, Petrie W, Nunzi MG, Massari CD (1991) Effects of phosphatidylserine in age-associated memory impairment. Neurology 41:644-649
52. Jorissen BL, Brouns F, Van Boxtel MP, Ponds RW, Verhey FR, Jolles J, Riedel WJ (2001) The influence of soy-derived phosphatidylserine on cognition in age-associated memory impairment Nutr Neurosci 4:121-134
53. Benton D, Donohoe RT (2005) The influence of phosphatidylserine and carnitine on the mood and the cognitive functioning of those over fifty-five years of age (unpublished findings)
54. Crook T, Bartus RT, Ferris SH, Whitehouse P, Cohen GD, Geshon S (1986) Age-associated memory impairment: proposed diagnostic criteria and measures of clinical change: report of a National Institute of Mental Health Work Group. Dev Neuropsychol 2:261-276
55. Schreiber S, Kampf-Sherf O, Gorfine M, Kelly D, Oppenheim Y, Lerer B (2000) An open trial of plant-source derived phosphatidylserine for treatment of age-related cognitive decline. Isr J Psychiatr Relat Sci 37:302-307
56. Ortega RM, Requejo AM, Andres P, Lopez-Sobaler AM, Quintas ME, Redondo MR, Navia B, Rivas T (1997) Dietary intake and cognitive function in a group of elderly people. Am J Clin Nutr 66:803-809
57. Engelhart MJ, Geerlings MI, Ruitenberg A, van Swieten JC, Hofman A, Witteman JC, Breteler MM (2002) Dietary intake of antioxidants and risk of Alzheimer disease. J Am Med Ass 287:3223-3239
58. Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Aggarwal N, Wilson RS, Scherr PA (2002) Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. J Am Med Ass 287:3230-3237
59. Morris MC, Evans DA, Bienias JL, Tangney CC, Wilson RS (2002) Vitamin E and cognitive decline in older persons. Arch Neurol 59:1125-1132
60. Luchsinger JA, Tang MX, Shea S, Mayeux R (2003) Antioxidant vitamin intake and risk of Alzheimer disease. Arch Neurol 60:203-208
61. Perrig WJ, Perrig P, Stahelin HB (1997) The relation between antioxidants and memory performance in the old and very old. J Amer Geriatr Soc 45:718-724
62. Perkins AJ, Hendrie HC, Callahan CM, Gao S, Unverzagt FW, Xu Y, Hall KS, Hui SL (1999) Association of antioxidants with memory in a multiethnic elderly sample using the Third National Health and Nutrition Examination Survey. Am J Epidemiol 150:37-44
63. Ortega RM, Requejo AM, Lopez-Sobaler AM, Andres P, Navia B, Perea JM, Robles F (2002) Cognitive function in elderly people is influenced by vitamin E status. J Nutr 132:2065-2068
64. Sram RJ, Binkova B, Topinka J, Kotesovec F, Fojtikova I, Hanel I, Klaschka J, Kocisova J, Prosek M, Machalek J (1993) Effect of antioxidant supplementation in an elderly population. Basic Life Sci 61:459-477
65. Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Growdon J, Cotman CW, Pfeiffer E, Schneider LS, Thal LJ (1997) A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. New Eng J Med 336:1216-1222
66. Smith A, Clark R, Nutt D, Haller J, Hayward SA, Perry K (1999) Anti-oxidant vitamins and mental performance of the elderly. Hum Psychopharm 14:459-471
67. Masaki KH, Losonczy KG, Izmirlian G, Foley DJ, Ross GW, Petrovitch H, Havlik R, White LR (2000) Association of vitamin E and C supplement use with cognitive function and dementia in elderly men. Neurology 28:1265-1272